These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8453278)

  • 1. Poxvirus vectors: cytoplasmic expression of transferred genes.
    Moss B
    Curr Opin Genet Dev; 1993 Feb; 3(1):86-90. PubMed ID: 8453278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia and other poxvirus expression vectors.
    Moss B
    Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poxviruses as expression vectors.
    Carroll MW; Moss B
    Curr Opin Biotechnol; 1997 Oct; 8(5):573-7. PubMed ID: 9353230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
    Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly attenuated poxvirus vectors.
    Tartaglia J; Cox WI; Taylor J; Perkus M; Riviere M; Meignier B; Paoletti E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1445-7. PubMed ID: 1466978
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing poxvirus vectors vaccine immunogenicity.
    García-Arriaza J; Esteban M
    Hum Vaccin Immunother; 2014; 10(8):2235-44. PubMed ID: 25424927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uses of poxviruses as vectors.
    Vanderplasschen A; Pastoret PP
    Curr Gene Ther; 2003 Dec; 3(6):583-95. PubMed ID: 14683453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of recombinant fowlpox viruses as vectors for poultry vaccines.
    Boyle DB; Coupar BE
    Virus Res; 1988 Jun; 10(4):343-56. PubMed ID: 2842977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.
    Xing Z; Santosuosso M; McCormick S; Yang TC; Millar J; Hitt M; Wan Y; Bramson J; Vordermeier HM
    Curr Gene Ther; 2005 Oct; 5(5):485-92. PubMed ID: 16250889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
    Moss B
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies vaccine. Developments employing molecular biology methods.
    Paolazzi CC; Pérez O; De Filippo J
    Mol Biotechnol; 1999 Apr; 11(2):137-47. PubMed ID: 10464768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poxvirus recombinant vaccines.
    Paoletti E
    Ann N Y Acad Sci; 1990; 590():309-25. PubMed ID: 2198832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on the early development of poxvirus vectors.
    Moss B
    Vaccine; 2013 Sep; 31(39):4220-2. PubMed ID: 23583893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy with poxvirus vectors.
    Moroziewicz D; Kaufman HL
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.
    Kanesa-thasan N; Smucny JJ; Hoke CH; Marks DH; Konishi E; Kurane I; Tang DB; Vaughn DW; Mason PW; Shope RE
    Vaccine; 2000 Oct; 19(4-5):483-91. PubMed ID: 11027812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.